Skip to main content
. 2016 Nov 26;8(32):52225–52236. doi: 10.18632/oncotarget.13660

Figure 4. LFA-3 is involved in NLC/CLL cell contact.

Figure 4

Representative experiment (left) or cumulative histogram (right) of PKH67 acquisition by CLL cells treated or not (UT) with blocking antibodies or by their respective isotype control antibodies (ctrl Ab) after 5 min or 4 h of contact with PKH67+ NLC, measured by flow cytometry (ratio PKH67 MFI vs PKH67 MFI UT 5 min). (A) anti-LFA3 (12 CLL patients). (B) anti-ICAM-1 (10 CLL patients). (C) anti-CD31 (10 CLL patients).